Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMEND vs EMTRICITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMEND vs EMTRICITABINE: Safety Overview

Metric EMEND EMTRICITABINE
Total FAERS Reports 155 3,718
Deaths Reported 18 499
Death Rate 11.6% 13.4%
Hospitalizations 53 797
Average Patient Age 53.4 yrs 42.2 yrs
% Female Patients N/A 41.9%
FDA Approval Date N/A Jul 2, 2003
Manufacturer N/A Gilead Sciences, Inc
Route N/A ORAL
Marketing Status N/A Prescription